Abstract:Disrupting the interaction between HIF1α and p300 is a promising strategy to modulate the hypoxia response of tumor cells. Herein, we designed a constrained peptide inhibitor derived from the CITED2/p300 complex to disturb the HIF1α/p300 interaction. Through truncation/mutation screening and a terminal aspartic acid-stabilized strategy, a constrained peptide was constructed with outstanding biochemical/biophysical properties, especially in binding affinity, cell penetration, and serum stability. To date, our study was the first one to showcase that stabilized peptides derived from CITED2 using helix-stabilizing methods acted as a promising candidate for modulating hypoxia-inducible signaling.The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/acs.jmedchem.1c01043.Primer sequence of genes for RT-PCR analysis; binding affinity of peptide L1-L8; analysis of CITED2-TAZ1 (PDB ID: 1P4Q) and modeling structure of CC3/p300; mutated peptide sequences and the comparison of mutated peptides in binding affinity and cell permeability; FACS analysis and CD spectra of peptides CC3 and CC3-cyclo; MST analysis of CC3-cyclo; trypsin stability of peptide inhibitors (CC3 and CC3-cyclo) in 24 h; immunofluorescence and confocal laser scanning microscopy (CLSM) analysis of the peptides in Hela cells; cell viability of Hela cells under hypoxia conditions; dual luciferase assays; HIF1α-related protein expression measurement when treated with peptides and chetomin under a hypoxia environment for 6–36 h; HIF1α-related protein expression measurement when treated with peptides with and without being FITC-labeled; replicate data and quantitative analysis of western blot images; quantitative analysis of wound-healing assay and transwell invasion assay; full Western Blot images; and MS spectra for all peptides (PDF)Molecular formula strings (CSV)PDB code 1P4Q was used for docking in CC3/p300 TAZ1 (PDB)This article has not yet been cited by other publications.

Developing a peptide to disrupt cohesin head domain interactions

Cohesin without Cohesion: A Novel Role for Pds5 in Saccharomyces cerevisiae

Development of D-box peptides to inhibit the Anaphase Promoting Complex/Cyclosome

Cohesins coordinate gene transcriptions of related function within Saccharomyces cerevisiae

The N-Terminal Non-Kinase-Domain-Mediated Binding of Haspin to Pds5B Protects Centromeric Cohesion in Mitosis

Cohesin ATPase activities regulate DNA binding and coiled-coil configuration

Smc3 Deacetylation by Hos1 Facilitates Efficient Dissolution of Sister Chromatid Cohesion during Early Anaphase

Peptide-Based Covalent Inhibitors Bearing Mild Electrophiles to Target a Conserved His Residue of the Bacterial Sliding Clamp

Potent Inhibition of HIF1α and p300 Interaction by a Constrained Peptide Derived from CITED2

The Cohesin ATPase cycle is mediated by specific conformational dynamics and interface plasticity of SMC1A and SMC3 ATPase domains

Faculty Opinions Recommendation of A Conserved ATP- and Scc2/4-dependent Activity for Cohesin in Tethering DNA Molecules.

Cyclic peptides target the aromatic cage of a PHD-finger reader domain to modulate epigenetic protein function

Structure of the Pds5-Scc1 Complex and Implications for Cohesin Function

Releasing Activity Disengages Cohesin's Smc3/Scc1 Interface in a Process Blocked by Acetylation

Covalent labeling of a chromatin reader domain using proximity-reactive cyclic peptides

Molecular Mechanism of Condensin I Activation by KIF4A

Molecular and Genetic Analysis of Condensin Function in Vertebrate Cells.

Smc3 acetylation, Pds5 and Scc2 control the translocase activity that establishes cohesin-dependent chromatin loops

Symmetric control of sister chromatid cohesion establishment

The acetyltransferase Eco1 elicits cohesin dimerization during S phase

Peptide-Based Complex Coacervates Stabilized by Cation-π Interactions for Cell Engineering